Review of the cardiac long-term effects of therapy for Hodgkin lymphoma.
about
Cancer survivorship research: a review of the literature and summary of current NCI-designated cancer center projectsKnock-down of PRAME increases retinoic acid signaling and cytotoxic drug sensitivity of Hodgkin lymphoma cellsRisks and diagnosis of coronary artery disease in Hodgkin lymphoma survivorsHodgkin's lymphoma emerging radiation treatment techniques: trade-offs between late radio-induced toxicities and secondary malignant neoplasms.Contribution of three-dimensional conformal intensity-modulated radiation therapy for women affected by bulky stage II supradiaphragmatic Hodgkin disease.Predicted risks of radiogenic cardiac toxicity in two pediatric patients undergoing photon or proton radiotherapy.Minimal Treatment of Low-Risk, Pediatric Lymphocyte-Predominant Hodgkin Lymphoma: A Report From the Children's Oncology GroupSingle or tandem autologous stem-cell transplantation for first-relapsed or refractory Hodgkin lymphoma: 10-year follow-up of the prospective H96 trial by the LYSA/SFGM-TC study group.Comparison of the impact of cancer between British and US long-term non-Hodgkin lymphoma survivors.Cardiotoxicity Following Cancer Treatment.Stratification of treatment intensity in relapsed pediatric Hodgkin lymphoma.Curcuma Contra Cancer? Curcumin and Hodgkin's Lymphoma.Increased healthcare use up to 10 years among relapse-free Hodgkin lymphoma survivors in the era of intensified chemotherapy and limited radiotherapy.Modulation of cardiovascular toxicity in Hodgkin lymphoma: potential role and mechanisms of aerobic trainingCardio-oncology: cardiovascular complications of cancer therapy.Stimulation of the hypoxia pathway modulates chemotherapy resistance in Hodgkin's lymphoma cells.Cancer-specific mortality, cure fraction, and noncancer causes of death among diffuse large B-cell lymphoma patients in the immunochemotherapy era.PD-1-PD-L1 immune-checkpoint blockade in B-cell lymphomas.Early and late outcomes after trans-catheter aortic valve implantation in patients with previous chest radiation.A case study evaluating deep inspiration breath-hold and intensity-modulated radiotherapy to minimise long-term toxicity in a young patient with bulky mediastinal Hodgkin lymphomaPrevalence of anthracycline-related cardiac dysfunction in long-term survivors of adult-onset lymphoma.Assessing the risk of cardiac toxicity after contemporary treatment for Hodgkin lymphoma: a systematic review.Therapy-Related Late Adverse Events in Hodgkin’s Lymphoma
P2860
Q27006424-AE10507C-B694-4074-95D8-846F91E4B09FQ28486108-A5DE6E1E-5EAE-4A2A-B540-713C9C8002F1Q33948488-675EE665-E86D-4646-82FF-ECD5042948E7Q36808805-6C313FD4-D79C-4DA3-A6F4-F5D94BB40036Q36898355-09E98044-3823-41F9-BBE4-F57393D526D5Q37114877-897D8DFB-0230-4BB4-BC87-68B271F03A99Q37169352-50A00705-5CC6-4A8A-936B-612F486B450BQ37216339-F0FD39F0-D2B0-4496-A54F-EE5FBCA72F76Q37609104-61029FF7-8369-4580-985B-5C37FA035628Q37663263-2180BCB8-CB5A-46C5-A77F-A4AE81533CA6Q38185983-78D55EBA-32EF-4342-89FE-D9AE6AD7E037Q38199088-1FB45965-1914-40C0-B71F-5193776B5D44Q38403661-D1E59242-B5BF-4717-AB17-D2AE617CD16EQ38559153-0792187A-9CA2-4FED-BC48-3C59EBF1F8EDQ38665281-F7B70F9F-3139-41A4-877A-8FAFED5D484EQ38807893-9E7CF9C2-6AEC-4049-8A73-82A313F91A51Q38808749-FB0F4AC3-706D-4F7C-8A17-039AE5F110BCQ38996724-78057ABB-0075-43D3-9433-6E2623234D77Q40780308-DFE83E59-EE65-4869-A613-39AAAA6676DBQ42315719-3A0941C9-9442-463C-AD87-65FFD400AC1FQ46004410-CB55B886-6EFA-4B01-B93A-0AE6C60E9007Q48161546-6398A2A0-726E-4A3A-AF01-52A983B27722Q58920329-5DA3C714-28A3-4C78-9633-607987B4D580
P2860
Review of the cardiac long-term effects of therapy for Hodgkin lymphoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 May 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Review of the cardiac long-term effects of therapy for Hodgkin lymphoma.
@en
Review of the cardiac long-term effects of therapy for Hodgkin lymphoma.
@nl
type
label
Review of the cardiac long-term effects of therapy for Hodgkin lymphoma.
@en
Review of the cardiac long-term effects of therapy for Hodgkin lymphoma.
@nl
prefLabel
Review of the cardiac long-term effects of therapy for Hodgkin lymphoma.
@en
Review of the cardiac long-term effects of therapy for Hodgkin lymphoma.
@nl
P2860
P1476
Review of the cardiac long-term effects of therapy for Hodgkin lymphoma.
@en
P2093
Andrea K Ng
P2860
P356
10.1111/J.1365-2141.2011.08713.X
P407
P577
2011-05-03T00:00:00Z